Yan-hong D. Lang
State Key Laboratory Of Oncology In South China, Guangdong Key Laboratory Of Nasopharyngeal Carcinoma Diagnosis And Therapy
Guangzhou, China
Guangzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
TSPAN1 inhibits metastasis of nasopharyngeal carcinoma via suppressing NF-kB signaling.
Journal: Cancer gene therapy
Published: June 21, 2023
Ulinastatin inhibits the metastasis of nasopharyngeal carcinoma by involving uPA/uPAR signaling.
Journal: Drug development research
Published: February 14, 2023
Correlated with better prognosis, CSTA inhibits metastasis of nasopharyngeal carcinoma cells via suppressing AKT signaling through promoting METTL3 degradation.
Journal: Biochimica et biophysica acta. Molecular basis of disease
Published: November 26, 2022
LACTB promotes metastasis of nasopharyngeal carcinoma via activation of ERBB3/EGFR-ERK signaling resulting in unfavorable patient survival.
Journal: Cancer letters
Published: June 18, 2020
Antioxidants suppress radiation-induced apoptosis via inhibiting MAPK pathway in nasopharyngeal carcinoma cells.
Journal: Biochemical and biophysical research communications
Published: March 25, 2020
PTPN3 Inhibits the Growth and Metastasis of Clear Cell Renal Cell Carcinoma via Inhibition of PI3K/AKT Signaling.
Journal: Molecular cancer research : MCR
Published: December 03, 2019
Candidate tumor suppressor gene IRF6 is involved in human breast cancer pathogenesis via modulating PI3K-regulatory subunit PIK3R2 expression.
Journal: Cancer management and research
Published: January 26, 2019
GTSE1 is involved in breast cancer progression in p53 mutation-dependent manner.
Journal: Journal of experimental & clinical cancer research : CR
Published: November 04, 2018
Global expression profiling and pathway analysis of mouse mammary tumor reveals strain and stage specific dysregulated pathways in breast cancer progression.
Journal: Cell cycle (Georgetown, Tex.)
Published: May 02, 2018
Along with its favorable prognostic role, CLCA2 inhibits growth and metastasis of nasopharyngeal carcinoma cells via inhibition of FAK/ERK signaling.
Journal: Journal of experimental & clinical cancer research : CR
Published: December 07, 2017
Last Updated: 09/26/2026